Physician profile
Deepa Vijay
NPI 1750460630
$1,186.66
in general payments reported to CMS, 2019-2025
14 companies · $176 in 2025
The $176 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2020: $87.97 · 2021: $209 · 2022: $142 · 2023: $145 · 2024: $312 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $633.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $365.71 | 2019-2024 | |
| Supernus Pharmaceuticals, INC. | $206.97 | 2024 | Qelbree |
| Sanofi Pasteur INC. | $143.32 | 2021-2025 | |
| Alk-Abello, INC | $86.36 | 2025 | Neffy |
| Merck Sharp & Dohme LLC | $82.09 | 2023-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Takeda Pharmaceuticals U.S.A., INC. | $64.68 | 2020-2021 | |
| Cranial Technologies, INC | $46.77 | 2019-2025 | Doc Band |
| Corium, LLC | $44.74 | 2022 | |
| Ironshore Pharmaceuticals INC. | $37.75 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $26.04 | 2022 | |
| Kaleo, INC. | $24.43 | 2023 | Auvi-Q |
| Ars Pharmaceuticals Operations, INC. | $22.52 | 2025 | Neffy |
| Seqirus USA INC | $18.69 | 2022 | |
| Genzyme Corporation | $16.59 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepa Vijay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.